PMID- 34198132
OWN - NLM
STAT- MEDLINE
DCOM- 20210928
LR  - 20211204
IS  - 1879-0046 (Electronic)
IS  - 0376-8716 (Linking)
VI  - 226
DP  - 2021 Sep 1
TI  - Racial/ethnic disparities in the use of medications for opioid use disorder 
      (MOUD) and their effects on residential drug treatment outcomes in the US.
PG  - 108849
LID - S0376-8716(21)00344-6 [pii]
LID - 10.1016/j.drugalcdep.2021.108849 [doi]
AB  - BACKGROUND: This study examines racial/ethnic disparities in the use of 
      medications for opioid use disorder (MOUD) in residential treatment and the 
      influence of race/ethnicity on the association between MOUD use and treatment 
      retention and completion. METHODS: Data were extracted from SAMHSA's 2015-2017 
      Treatment Episode Dataset-Discharge (TEDS-D) datasets for adult opioid 
      admissions/discharges to short-term (ST) (30 days or less) (N = 83,032) or 
      long-term (LT) (> 30 days) residential treatment settings (N=61,626). Logistic 
      regression estimated the likelihood of MOUD use among racial/ethnic groups and 
      the moderation of race/ethnicity on the probability of treatment completion and 
      retention, controlling for background factors. RESULTS: After adjusting for 
      covariates, compared to Whites, MOUD use was less likely for Blacks in ST (OR = 
      0.728) and LT settings (OR = 0.725) and slightly less likely for Hispanics in ST 
      settings (OR = 0.859) but slightly more likely for Hispanics in LT settings (OR = 
      1.107). In ST settings, compared to Whites, the positive effect of MOUD on 
      retention was enhanced for Blacks (OR = 1.191) and Hispanics (OR = 1.234), and 
      the positive effect on treatment completion was enhanced for Hispanics (OR = 
      1.144). In LT settings, the negative association between MOUD and treatment 
      completion was enhanced for Hispanics (OR = 0.776). CONCLUSIONS: Access to 
      medications for opioid use disorder in short term residential treatment is 
      particularly beneficial for Blacks and Hispanics, though adjusted models indicate 
      they are less likely to receive it compared to Whites. Results are mixed for 
      long-term residential treatment. Residential addiction treatment may represent an 
      important setting for mitigating low rates of medication initiation and early 
      discontinuation for minority patients.
CI  - Copyright (c) 2021 Elsevier B.V. All rights reserved.
FAU - Stahler, Gerald J
AU  - Stahler GJ
AD  - Department of Geography and Urban Studies, Temple University, Philadelphia, PA, 
      19122, USA. Electronic address: jstahler@temple.edu.
FAU - Mennis, Jeremy
AU  - Mennis J
AD  - Department of Geography and Urban Studies, Temple University, Philadelphia, PA, 
      19122, USA. Electronic address: jeremy.mennis@temple.edu.
FAU - Baron, David A
AU  - Baron DA
AD  - Department of Psychiatry, Western University of Health Sciences, Pomona, CA, 
      91766, USA; Department of Psychiatry and Behavioral Sciences, Keck School of 
      Medicine, University of Southern California, Los Angeles, CA, 90033, USA. 
      Electronic address: dbaron@westernu.edu.
LA  - eng
PT  - Journal Article
DEP - 20210624
PL  - Ireland
TA  - Drug Alcohol Depend
JT  - Drug and alcohol dependence
JID - 7513587
RN  - 0 (Pharmaceutical Preparations)
SB  - IM
MH  - Adult
MH  - Ethnicity
MH  - Hispanic or Latino
MH  - Humans
MH  - *Opioid-Related Disorders/drug therapy
MH  - *Pharmaceutical Preparations
MH  - Residential Treatment
MH  - Treatment Outcome
OTO - NOTNLM
OT  - Medications for opioid use disorder
OT  - Racial/ethnic disparities
OT  - Residential treatment
OT  - Treatment completion
OT  - Treatment outcomes
OT  - Treatment retention
EDAT- 2021/07/02 06:00
MHDA- 2021/09/29 06:00
CRDT- 2021/07/01 20:22
PHST- 2021/02/15 00:00 [received]
PHST- 2021/05/05 00:00 [revised]
PHST- 2021/05/13 00:00 [accepted]
PHST- 2021/07/02 06:00 [pubmed]
PHST- 2021/09/29 06:00 [medline]
PHST- 2021/07/01 20:22 [entrez]
AID - S0376-8716(21)00344-6 [pii]
AID - 10.1016/j.drugalcdep.2021.108849 [doi]
PST - ppublish
SO  - Drug Alcohol Depend. 2021 Sep 1;226:108849. doi: 
      10.1016/j.drugalcdep.2021.108849. Epub 2021 Jun 24.